Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic capital loss on anyone. Imagine if you held Inogen, Inc. (NASDAQ:INGN) for half a ...

Inogen (INGN) continues its turnaround, showing progress in revenue growth and margins, but the pace remains slower and riskier than the market desires. INGN posted positive adjusted EBITDA and raised ...

GOLETA, Calif. (AP) — GOLETA, Calif. (AP) — Inogen Inc. (INGN) on Wednesday reported a loss of $5.3 million in its third quarter. On a per-share basis, the Goleta, California-based company said it had ...

GOLETA, Calif. - Inogen, Inc. (NASDAQ:INGN) has appointed Naga Rameswamy as Chief Technology Officer, effective September 29, the respiratory medical technology company announced Thursday in a press ...

Needham analyst Mike Matson upgraded Inogen, Inc (NASDAQ:INGN) from Hold to Buy, with a price forecast of $12. On May 7, the company reported its first-quarter results. Total revenue in the quarter ...

Inogen, Inc. INGN recently announced a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (Yuwell), a global home healthcare medical device manufacturer with a ...

In 2024, Inogen introduced new products, including Rove 4, and received FDA clearance for the SIMEOX 200 device, expanding its global product offerings. The company maintains a strong financial ...

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management ...

Inogen INGN witnessed strong momentum in the year-to-date period. Shares of the company have surged 127.1% compared with 9.1% growth of the industry. The S&P 500 composite has risen 17.4% during the ...